Human galectins
    1.
    发明授权
    Human galectins 失效
    人类半乳凝素

    公开(公告)号:US5837493A

    公开(公告)日:1998-11-17

    申请号:US788584

    申请日:1997-01-23

    CPC分类号: C07K14/4726 A61K38/00

    摘要: The present invention provides two novel human galectins (designated individually as GAL-5HA and GAL-5HB, and collectively as GAL-5H) and polynucleotides which identify and encode GAL-5H. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding GAL-5H and a method for producing GAL-5H. The invention also provides for use of GAL-5H and agonists, antibodies, or antagonists specifically binding GAL-5H, in the prevention and treatment of diseases associated with expression of GAL-5H. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding GAL-5H for the treatment of diseases associated with the expression of GAL-5H. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding GAL-5H.

    摘要翻译: 本发明提供两种新型人半乳凝素(单独命名为GAL-5HA和GAL-5HB,统称为GAL-5H)和识别和编码GAL-5H的多核苷酸。 本发明还提供了遗传工程改造的表达载体和宿主细胞,其包含编码GAL-5H的核酸序列和产生GAL-5H的方法。 本发明还提供使用GAL-5H和特异性结合GAL-5H的激动剂,抗体或拮抗剂来预防和治疗与GAL-5H表达相关的疾病。 另外,本发明提供了反义分子用于编码GAL-5H的多核苷酸用于治疗与GAL-5H表达相关的疾病的用途。 本发明还提供利用多核苷酸或其片段或其补体以及特异性结合GAL-5H的抗体的诊断测定法。